被纳入医保的脑机接口 我们什么时候能用上？

Core Insights - The concept of brain-computer interfaces (BCIs) has been around since the 1970s, but their practical application remains limited despite advancements in personal computing [2][3] - In September 2023, Zhejiang Province included "non-invasive BCI adaptation fees" in basic medical insurance, indicating the technology's potential and the push for its integration into healthcare [2][11] - Global companies, including Synchron and Neuralink, are advancing BCI applications, with claims of enabling paralyzed patients to control devices and future possibilities like consciousness uploading [4][6] Industry Development - China's BCI technology is rapidly evolving, with significant milestones such as the first invasive BCI clinical trial completed in March 2025, allowing a patient to play games using thought [7] - In September 2025, a BCI surgery for epilepsy treatment was successfully performed at Southern Medical University, showcasing the technology's clinical applications [8] - The BCI market in China is projected to grow from 3.2 billion yuan in 2024 to over 5.5 billion yuan by 2027, reflecting increasing demand and investment [9] Policy and Support - The early inclusion of BCI technology in medical insurance aims to lower barriers for patients and accelerate its practical application, laying a foundation for widespread adoption [11] - The "Implementation Opinions on Promoting the Innovative Development of the BCI Industry" set clear industry goals for 2025, emphasizing safety and reliability alongside technological advancement [12] Regional Leadership - Guangdong Province is leading in BCI development, with 80 key enterprises in the field by 2024, covering the entire industry chain from research to application [14] - The province has demonstrated strong innovation capabilities, with 360 related patents filed by 2024, ranking second nationally [15] - Guangdong's robust medical device sector, with 4,883 production enterprises, supports its BCI advancements, particularly in the second and third categories of medical devices [17][19]